INFLUENCE OF URINARY PH ON ELIMINATION OF MEXILETINE

被引:43
作者
KIDDIE, MA
KAYE, CM
TURNER, P
SHAW, TRD
机构
[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
[2] ST BARTHOLOMEWS HOSP,DEPT CARDIOL,LONDON EC1A 7BE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1974.tb00241.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:229 / 232
页数:4
相关论文
共 15 条
[1]  
ALLEN JD, 1970, BRIT J PHARMACOL, V39, P183
[2]  
BECKETT AH, 1965, LANCET, V1, P303
[3]  
CAMPBELL NP, 1973, LANCET, V2, P404
[4]   URINARY PH [J].
ELLIOT, JS ;
SHARP, RF ;
LEWIS, L .
JOURNAL OF UROLOGY, 1959, 81 (02) :339-343
[5]  
Gibaldi M., 1971, INTRO BIOPHARMACEUTI
[7]   A STUDY OF THE INVERSE RELATIONSHIP BETWEEN PKA AND RATE OF RENAL EXCRETION OF PHENYLBUTAZONE ANALOGS IN MAN AND DOG [J].
GUTMAN, AB ;
DAYTON, PG ;
YU, TF ;
BERGER, L ;
CHEN, W ;
SICAM, LE ;
BURNS, JJ .
AMERICAN JOURNAL OF MEDICINE, 1960, 29 (06) :1017-1033
[8]  
Kalman SM, 1968, PRINCIPLES DRUG ACTI
[9]  
KAYE CM, 1973, BRIT J PHARMACOL, V49, pP155
[10]  
KIDDIE MA, 1973, BRIT J PHARMACOL, V47, pP674